vs
BROADWIND, INC.（BWEN）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
BROADWIND, INC.的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$37.7M vs $19.6M），BROADWIND, INC.同比增速更快（12.4% vs -11.5%），BROADWIND, INC.自由现金流更多（$-187.0K vs $-23.1M），过去两年BROADWIND, INC.的营收复合增速更高（0.2% vs -12.2%）
Broadwind Inc.是一家总部位于美国的工业制造企业，主营重型结构部件、齿轮系统的生产及相关售后服务，业务覆盖可再生能源、基础设施与重工业领域，主要为北美市场的风电项目、公用事业能源工程等供应核心零部件。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BWEN vs LAB — 直观对比
营收规模更大
BWEN
是对方的1.9倍
$19.6M
营收增速更快
BWEN
高出23.9%
-11.5%
自由现金流更多
BWEN
多$22.9M
$-23.1M
两年增速更快
BWEN
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.7M | $19.6M |
| 净利润 | — | $-34.7M |
| 毛利率 | 8.8% | 48.5% |
| 营业利润率 | -0.2% | -168.5% |
| 净利率 | — | -177.4% |
| 营收同比 | 12.4% | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $-0.03 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BWENLAB
| Q4 25 | $37.7M | — | ||
| Q3 25 | $44.2M | $19.6M | ||
| Q2 25 | $39.2M | $21.8M | ||
| Q1 25 | $36.8M | $40.8M | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $35.5M | $22.1M | ||
| Q2 24 | $36.5M | $22.5M | ||
| Q1 24 | $37.6M | $45.5M |
净利润BWENLAB
| Q4 25 | — | — | ||
| Q3 25 | $7.5M | $-34.7M | ||
| Q2 25 | $-989.0K | $-33.5M | ||
| Q1 25 | $-370.0K | $-26.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $74.0K | $-26.9M | ||
| Q2 24 | $482.0K | $-45.7M | ||
| Q1 24 | $1.5M | $-32.2M |
毛利率BWENLAB
| Q4 25 | 8.8% | — | ||
| Q3 25 | 10.2% | 48.5% | ||
| Q2 25 | 10.1% | 48.8% | ||
| Q1 25 | 11.7% | 48.4% | ||
| Q4 24 | 11.3% | — | ||
| Q3 24 | 14.6% | 54.9% | ||
| Q2 24 | 15.3% | 46.1% | ||
| Q1 24 | 17.6% | 53.1% |
营业利润率BWENLAB
| Q4 25 | -0.2% | — | ||
| Q3 25 | 19.7% | -168.5% | ||
| Q2 25 | -0.4% | -118.1% | ||
| Q1 25 | 0.5% | -80.8% | ||
| Q4 24 | -0.9% | — | ||
| Q3 24 | 3.3% | -120.9% | ||
| Q2 24 | 3.4% | -134.5% | ||
| Q1 24 | 5.5% | -132.2% |
净利率BWENLAB
| Q4 25 | — | — | ||
| Q3 25 | 16.9% | -177.4% | ||
| Q2 25 | -2.5% | -153.7% | ||
| Q1 25 | -1.0% | -63.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.2% | -122.0% | ||
| Q2 24 | 1.3% | -203.3% | ||
| Q1 24 | 4.0% | -70.6% |
每股收益（稀释后）BWENLAB
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $0.32 | $-0.09 | ||
| Q2 25 | $-0.04 | $-0.09 | ||
| Q1 25 | $-0.02 | $-0.07 | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.00 | $-0.07 | ||
| Q2 24 | $0.02 | $-0.12 | ||
| Q1 24 | $0.07 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $456.0K | $129.4M |
| 总债务越低越好 | $10.1M | — |
| 股东权益账面价值 | $66.3M | $399.7M |
| 总资产 | $116.8M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资BWENLAB
| Q4 25 | $456.0K | — | ||
| Q3 25 | $1.2M | $129.4M | ||
| Q2 25 | $1.0M | $158.6M | ||
| Q1 25 | $1.2M | $150.9M | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $1.4M | $210.6M | ||
| Q2 24 | $938.0K | $269.8M | ||
| Q1 24 | $1.1M | $287.1M |
总债务BWENLAB
| Q4 25 | $10.1M | — | ||
| Q3 25 | $10.3M | — | ||
| Q2 25 | $26.1M | — | ||
| Q1 25 | $12.2M | — | ||
| Q4 24 | $9.2M | — | ||
| Q3 24 | $16.9M | $55.2M | ||
| Q2 24 | $18.0M | $55.1M | ||
| Q1 24 | $7.7M | $55.0M |
股东权益BWENLAB
| Q4 25 | $66.3M | — | ||
| Q3 25 | $66.9M | $399.7M | ||
| Q2 25 | $59.0M | $424.5M | ||
| Q1 25 | $59.3M | $454.6M | ||
| Q4 24 | $59.4M | — | ||
| Q3 24 | $59.6M | $489.3M | ||
| Q2 24 | $59.1M | $510.3M | ||
| Q1 24 | $58.0M | $577.3M |
总资产BWENLAB
| Q4 25 | $116.8M | — | ||
| Q3 25 | $119.6M | $539.6M | ||
| Q2 25 | $130.5M | $557.0M | ||
| Q1 25 | $129.3M | $579.6M | ||
| Q4 24 | $128.3M | — | ||
| Q3 24 | $125.1M | $681.5M | ||
| Q2 24 | $122.5M | $708.7M | ||
| Q1 24 | $123.1M | $777.7M |
负债/权益比BWENLAB
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.28× | 0.11× | ||
| Q2 24 | 0.30× | 0.11× | ||
| Q1 24 | 0.13× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $857.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-187.0K | $-23.1M |
| 自由现金流率自由现金流/营收 | -0.5% | -118.1% |
| 资本支出强度资本支出/营收 | 2.8% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-19.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流BWENLAB
| Q4 25 | $857.0K | — | ||
| Q3 25 | $4.3M | $-22.2M | ||
| Q2 25 | $-12.5M | $-20.7M | ||
| Q1 25 | $-8.0M | $-30.3M | ||
| Q4 24 | $14.8M | — | ||
| Q3 24 | $2.4M | $-27.9M | ||
| Q2 24 | $-9.3M | $-39.0M | ||
| Q1 24 | $5.9M | $-62.5M |
自由现金流BWENLAB
| Q4 25 | $-187.0K | — | ||
| Q3 25 | $3.8M | $-23.1M | ||
| Q2 25 | $-13.7M | $-22.6M | ||
| Q1 25 | $-9.0M | $-35.3M | ||
| Q4 24 | $14.5M | — | ||
| Q3 24 | $1.7M | $-30.1M | ||
| Q2 24 | $-10.1M | $-41.0M | ||
| Q1 24 | $4.1M | $-63.3M |
自由现金流率BWENLAB
| Q4 25 | -0.5% | — | ||
| Q3 25 | 8.6% | -118.1% | ||
| Q2 25 | -34.8% | -103.6% | ||
| Q1 25 | -24.3% | -86.6% | ||
| Q4 24 | 43.1% | — | ||
| Q3 24 | 4.8% | -136.4% | ||
| Q2 24 | -27.6% | -182.2% | ||
| Q1 24 | 10.9% | -138.9% |
资本支出强度BWENLAB
| Q4 25 | 2.8% | — | ||
| Q3 25 | 1.1% | 4.5% | ||
| Q2 25 | 3.1% | 8.7% | ||
| Q1 25 | 2.5% | 12.4% | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 2.1% | 10.2% | ||
| Q2 24 | 2.2% | 8.6% | ||
| Q1 24 | 4.6% | 1.7% |
现金转化率BWENLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.57× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.99× | — | ||
| Q2 24 | -19.26× | — | ||
| Q1 24 | 3.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BWEN
| Heavy Fabrications | $21.6M | 57% |
| Industrial Solutions | $9.4M | 25% |
| Gearing | $7.0M | 19% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
